Conditionally inducible tau mice - Designing a better mouse model of neurodegenerative diseases

Genes, Brain and Behavior

Volumn 7, Issue SUPPL. 1, 2008, Pages 12-27

  Janus, C ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Amyloid; Mouse models; Neurodegeneration; Tangles; Tau; Tauopathy; Transgenic

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PROTEIN RTG4510; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE SEVERITY; GENE DELETION; GENE MUTATION; GENE REPLICATION; GENETIC MODEL; MOLECULAR BIOLOGY; MOUSE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; TAU PROTEINS; TAUOPATHIES;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 37749006539     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2007.00375.x     Document Type: Conference Paper

References (184)

1. Albert, M.S 1996) Cognitive and neurobiologic markers of early Alzheimer's disease. Proc Natl Acad Sci U S A 93, 13547 13551.
2. Alvarez, A., Opazo, C., Alarcon, R., Garrido, J. Inestrosa, N.C 1997) Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 272, 348 361.
3. Alzheimer, A 1907) Über eine eigenartige Erkankung der Hirnrinde. Allg Z Psychiatrie Psychisch-Gerlichtlich Med 64, 146 148.
4. Andorfer, C., Kress, Y., Espinoza, M., de Silva, R., Tucker, K.L., Barde, Y.A., Duff, K. Davies, P 2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 86, 582 590.
5. Andorfer, C., Acker, C.M., Kress, Y., Hof, P.R., Duff, K. Davies, P 2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 25, 5446 5454.
6. Andreadis, A., Brown, W.M. Kosik, K.S 1992) Structure and novel exons of the human tau gene. Biochemistry 31, 10626 10633.
7. Arriagada, P.V., Growdon, J.H., Hedley-Whyte, E.T. Hyman, B.T 1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631 639.
8. Ashe, K 2001) Learning and memory in transgenic mice modelling Alzhiemer's disease. Learn Mem 8, 301 308.
9. Ashe, K.H 2005) Mechanisms of memory loss in Abeta and tau mouse models. Biochem Soc Trans 33, 591 594.
10. Baker, M., Mackenzie, I.R., Pickering-Brown, S.M. et al 2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916 919.
11. Banbury Conference on Genetic Background in Mice 1997) Mutant mice and neuroscience: recommendations. Neuron 19, 755 759.
12. Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K. Wisniewski, H.M 1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477, 90 99.
13. Bard, F., Cannon, C., Barbour, R. et al 2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6, 916 919.
14. Barghorn, S. Mandelkow, E 2002) Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. Biochemistry 41, 14885 14896.
15. Barker, W.W., Luis, C.A., Kashuba, A. et al 2002) Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 16, 203 212.
16. Baxter, M.G. Gallagher, M 1996) Intact spatial learning in both young and aged rats following selective removal of hippocampal cholinergic input. Behav Neurosci 110, 460 467.
17. Bayer, T.A. Wirths, O 2007) Review on the APP/PS1 KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment. Genes Brain Behav 7 (Suppl. 1 6 11.
18. Beeri, R., Andres, C., Lev-Lehman, E., Timberg, R., Huberman, T., Shani, M. Soreq, H 1995) Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 5, 1063 1071.
19. Berger, Z., Roder, H., Hanna, A., Carlson, A., Rangachari, V., Yue, M., Wszolek, Z., Ashe, K., Knight, J., Dickson, D., Andorfer, C., Rosenberry, T.L., Lewis, J., Hutton, M. Janus, C 2007) Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci 27, 3650 3662.
20. Braak, H. Braak, E 1994) Pathology of Alzheimer's disease. In Calne, D.B. (ed Neurodegenerative Diseases. Saunders, Philadelphia, PA, pp. 585 613.
21. Braak, H. Braak, E 1997a) Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 18, S85 S88.
22. Braak, H. Braak, E 1997b) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18, 351 357.
23. Brandt, R. Lee, G 1993a) Functional organization of microtubule- associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro. J Biol Chem 268, 3414 3419.
24. Brandt, R. Lee, G 1993b) The balance between tau protein's microtubule growth and nucleation activities: implications for the formation of axonal microtubules. J Neurochem 61, 997 1005.
25. Brandt, R., Hundelt, M. Shahani, N 2005) Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim Biophys Acta 1739, 331 354.
26. Brody, D.L. Holtzman, D.M 2006) Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury. Exp Neurol 197, 330 340.
27. Bronner, I.F., ter Meulen, B.C., Azmani, A., Severijnen, L.A., Willemsen, R., Kamphorst, W., Ravid, R., Heutink, P. van Swieten, J.C 2005) Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain 128, 2645 2653.
28. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. Hof, P.R 2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33, 95 130.
29. Calhoun, M.E., Wiederhold, K.H., Abramowski, D., Phinney, A.L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B. Jucker, M 1998) Neuron loss in APP transgenic mice. Nature 395, 755 756.
30. Campion, D., Flaman, J.M., Brice, A., Hannequin, D., Dubois, B., Martin, C., Moreau, V., Charbonnier, F., Didierjean, O. Tardieu, S 1995) Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet 4, 2373 2377.
31. Chartier-Harlin, M.C., Crawford, F., Hamandi, K., Mullan, M., Goate, A., Hardy, J., Backhovens, H., Martin, J.J. Broeckhoven, C.V 1991a) Screening for the beta-amyloid precursor protein mutation (APP717: Val - -Ile) in extended pedigrees with early onset Alzheimer's disease. Neurosci Lett 129, 134 135.
32. Chartier-Harlin, M.C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P. Hardy, J 1991b) Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353, 844 846.
33. Cheng, I.H., Scearce-Levie, K., Legleiter, J., Palop, J.J., Gerstein, H., Bien-Ly, N., Puolivali, J., Lesne, S., Ashe, K.H., Muchowski, P.J. Mucke, L 2007) Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 282, 23818 23828.
34. Chin, S.S. Goldman, J.E 1996) Glial inclusions in CNS degenerative diseases. J Neuropathol Exp Neurol 55, 499 508.
35. Chishti, M.A., Yang, D.S., Janus, C. et al 2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276, 21562 21570.
36. Ciechanover, A 2001) Linking ubiquitin, parkin and synphilin-1. Nat Med 7, 1108 1109.
37. Clark, L.N., Poorkaj, P., Wszolek, Z., Geschwind, D.H., Nasreddine, Z.S., Miller, B., Li, D., Payami, H., Awert, F., Markopoulou, K., Andreadis, A., D'Souza, I., Lee, V.M., Reed, L., Trojanowski, J.Q., Zhukareva, V., Bird, T., Schellenberg, G. Wilhelmsen, K.C 1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 95, 13103 13107.
38. Cleveland, D.W., Hwo, S.Y. Kirschner, M.W 1977a) Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol 116, 227 247.
39. Cleveland, D.W., Hwo, S.Y. Kirschner, M.W 1977b) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116, 207 225.
40. Crabbe, J.C., Wahlsten, D. Dudek, B.C 1999) Genetics of mouse behavior: interactions with laboratory environment. Science 284, 1670 1672.
41. Crawley, J.N. Paylor, R 1997) A proposed test battery and constellation of specific behavioural paradigms to investigate the behavioural phenotypes of transgenic and knockout mice. Horm Behav 31, 197 211.
42. Crawley, J.N., Belknap, J.K., Collins, A., Crabbe, J.C., Frankel, W., Henderson, N., Hitzemann, R.J., Maxson, S.C., Miner, L.L., Silva, A.J., Wehner, J.M., Wynshaw-Boris, A. Paylor, R 1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) 132, 107 124.
43. Crutcher, K.A., Scott, S.A., Liang, S., Everson, W.V. Weingartner, J 1993) Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 13, 2540 2550.
44. Cummings, J.L. Masterman, D.L 1998) Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease. J Clin Psychiatry 59, 23 30.
45. Dawson, H.N., Ferreira, A., Eyster, M.V., Ghoshal, N., Binder, L.I. Vitek, M.P 2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114, 1179 1187.
46. Delacourte, A., Flament, S., Dibe, E.M., Hublau, P., Sablonniere, B., Hemon, B., Sherrer, V. Defossez, A 1990) Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol (Berl) 80, 111 117.
47. Delacourte, A., Sergeant, N., Wattez, A., Maurage, C.A., Lebert, F., Pasquier, F. David, J.P 2002) Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp Gerontol 37, 1291 1296.
48. DeMattos, R.B., Bales, K.R., Cummins, D.J., Dodart, J.C., Paul, S.M. Holtzman, D.M 2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 98, 8850 8855.
49. Dermaut, B., Kumar-Singh, S., Rademakers, R., Theuns, J., Cruts, M. Van Broeckhoven, C 2005) Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum. Trends Genet 21, 664 672.
50. Dickson, C.T. Vanderwolf, C.H 1990) Animal-models of human amnesia and dementia - hippocampal and amygdala ablation compared with serotonergic and cholinergic blockade in the rat. Behav Brain Res 41, 215 227.
51. Dickson, D.W 2003) Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. ISN Neuropath Press, Basel.
52. Dodart, J.C., Bales, K.R., Gannon, K.S., Greene, S.J., DeMattos, R.B., Mathis, C., DeLong, C.A., Wu, S., Wu, X., Holtzman, D.M. Paul, S.M 2002a) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5, 452 457.
53. Dodart, J.C., Mathis, C., Bales, K.R. Paul, S.M 2002b) Does my mouse have Alzheimer's disease? Genes Brain Behav 1, 142 155.
54. Elizan, T.S., Hirano, A., Abrams, B.M., Need, R.L., Van Nuis, C. Kurland, L.T 1966) Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. Neurological reevaluation. Arch Neurol 14, 356 368.
55. Eriksen, J.L. Janus, C.G 2006) Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav Genet 37, 79 100.
56. Evans, D.A., Funkenstein, H.H., Albert, M.S., Scherr, P.A., Cook, N.R., Chown, M.J., Hebert, L.E., Hennekens, C.H. Taylor, J.O 1989) Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 262, 2551 2556.
57. Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., Menezes, P.R., Rimmer, E. Scazufca, M 2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112 2117.
58. Galvan, M., David, J.P., Delacourte, A., Luna, J. Mena, R 2001) Sequence of neurofibrillary changes in aging and Alzheimer's disease: a confocal study with phospho-tau antibody, AD2. J Alzheimers Dis 3, 417 425.
59. Games, D., Adams, D., Alessandrini, R. et al 1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523 527.
60. Garcia, M.F., Gordon, M.N., Hutton, M., Lewis, J., McGowan, E., Dickey, C.A., Morgan, D. Arendash, G.W 2004) The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer's transgenic mice. Neuroreport 15, 73 77.
61. Ghetti, B., Hutton, M. Wszolek, Z 2003) Frontotemporal dementia and parkinsonism linked to chromosome 17 associated with Tau gene mutations (FTDP-17 T). In Dickson, D. (ed Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. ISN Neuropath Press, Basel, pp. 81 155.
62. Glenner, G.G. Wong, C.W 1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885 890.
63. Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N. James, L 1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704 706.
64. Goedert, M. Jakes, R 2005) Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta 1739, 240 250.
65. Goedert, M., Wischik, C.M., Crowther, R.A., Walker, J.E. Klug, A 1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A 85, 4051 4055.
66. Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. Crowther, R.A 1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519 526.
67. Gossen, M. Bujard, H 1995) Efficacy of tetracycline-controlled gene expression is influenced by cell type: commentary. Biotechniques 19, 213 216 discussion 216-217.
68. Gotz, J 2001) Tau and transgenic animal models. Brain Res Brain Res Rev 35, 266 286.
69. Gotz, J., Tolnay, M., Barmettler, R., Chen, F., Probst, A. Nitsch, R.M 2001) Oligodendroglial tau filament formation in transgenic mice expressing G272V tau. Eur J Neurosci 13, 2131 2140.
70. Greenberg, B.D., Savage, M.J., Howland, D.S., Ali, S.M., Siedlak, S.L., Perry, G., Siman, R. Scott, R.W 1996) APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology. Neurobiol Aging 17, 153 171.
71. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y.C., Zaidi, M.S. Wisniewski, H.M 1986a) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084 6089.
72. Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M. Binder, L.I 1986b) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83, 4913 4917.
73. Gu, Y., Oyama, F. Ihara, Y 1996) Tau is widely expressed in rat tissues. J Neurochem 67, 1235 1244.
74. Hall, G.F. Yao, J 2005) Modeling tauopathy: a range of complementary approaches. Biochim Biophys Acta 1739, 224 239.
75. Hardy, J. Selkoe, D.J 2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353 356.
76. Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennett, D.A. Evans, D.A 2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60, 1119 1122.
77. Higgins, G.A. Jacobsen, H 2003) Transgenic mouse models of Alzheimer's disease: phenotype and application. Behav Pharmacol 14, 419 438.
78. Himmler, A., Drechsel, D., Kirschner, M.W. Martin, D.W. Jr. (1989) Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol Cell Biol 9, 1381 1388.
79. Hirano, A., Malamud, N., Elizan, T.S. Kurland, L.T 1966) Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam. Further pathologic studies. Arch Neurol 15, 35 51.
80. Hirokawa, N., Shiomura, Y. Okabe, S 1988) Tau proteins: the molecular structure and mode of binding on microtubules. J Cell Biol 107, 1449 1459.
81. Hock, C., Konietzko, U., Streffer, J.R., Tracy, J., Signorell, A., Muller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., Wollmer, M.A., Umbricht, D., de Quervain, D.J., Hofmann, M., Maddalena, A., Papassotiropoulos, A. Nitsch, R.M 2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38, 547 554.
82. Hof, P.R., Bouras, C., Perl, D.P., Sparks, D.L., Mehta, N. Morrison, J.H 1995) Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol 52, 379 391.
83. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F.S. Cole, G 1996) Correlative memory deficits, a-beta elevation, and amyloid plaques in transgenic mice. Science 274, 99 102.
84. Hsiao, K.K., Borchelt, D.R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., Iadecola, C., Clark, B. Carlson, G 1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203 1218.
85. Hutton, M., Lendon, C.L., Rizzu, P. et al 1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702 705.
86. Hyman, B.T., Augustinack, J.C. Ingelsson, M 2005) Transcriptional and conformational changes of the tau molecule in Alzheimer's disease. Biochim Biophys Acta 1739, 150 157.
87. Ingelson, M., Vanmechelen, E. Lannfelt, L 1996) Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation. Neurosci Lett 220, 9 12.
88. Irizarry, M.C., McNamara, M., Fedorchak, K., Hsiao, K. Hyman, B.T 1997a) APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56, 965 973.
89. Irizarry, M.C., Soriano, F., McNamara, M., Page, K.J., Schenk, D., Games, D. Hyman, B.T 1997b) Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17, 7053 7059.
90. Janus, C 2004) Search strategies used by APP transgenic mice during spatial navigation in the Morris water maze. Learn Mem 11, 337 346.
91. Janus, C. Westaway, D 2001) Transgenic mouse models of Alzheimer's disease. Physiol Behav 73, 873 886.
92. Janus, C., Chishti, M.A. Westaway, D 2000a) Transgenic mouse models of Alzheimer's disease. Biochim Biophys Acta 1502, 63 75.
93. Janus, C., Pearson, J., McLaurin, J., Mathews, P.M., Jiang, Y., Schmidt, S.D., Chishti, M.A., Horne, P., Heslin, D., French, J., Mount, H.T.J., Nixon, R.A., Mercken, M., Bergeron, C., Fraser, P.E., St George-Hyslop, P. Westaway, D 2000b) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979 982.
94. Jensen, M.T., Mottin, M.D., Cracchiolo, J.R., Leighty, R.E. Arendash, G.W 2005) Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience 130, 667 684.
95. Jimenez, A.J., Garcia-Fernandez, J.M., Gonzalez, B. Foster, R.G 1996) The spatio-temporal pattern of photoreceptor degeneration in the aged rd/rd mouse retina. Cell Tissue Res 284, 193 202.
96. Kidd, M 1964) Alzheimer's disease - an electron microscopical study. Brain 87, 307 320.
97. Kiuchi, A., Otsuka, N., Namba, Y., Nakano, I. Tomonaga, M 1991) Presenile appearance of abundant Alzheimer's neurofibrillary tangles without senile plaques in the brain in myotonic dystrophy. Acta Neuropathol (Berl) 82, 1 5.
98. Kosik, K.S. Shimura, H 2005) Phosphorylated tau and the neurodegenerative foldopathies. Biochim Biophys Acta 1739, 298 310.
99. Kosik, K.S., Joachim, C.L. Selkoe, D.J 1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A 83, 4044 4048.
100. Kosik, K.S., Orecchio, L.D., Bakalis, S. Neve, R.L 1989) Developmentally regulated expression of specific tau sequences. Neuron 2, 1389 1397.
101. Kotilinek, L.A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B.T., Younkin, S. Ashe, K.H 2002) Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci 22, 6331 6335.
102. Lamb, B.T., Sisodia, S.S., Lawler, A.M., Slunt, H.H., Kitt, C.A., Kearns, W.G., Pearson, P.L., Price, D.L. Gearhart, J.D 1993) Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice. Nat Genet 5, 22 30.
103. Le Cudennec, C., Faure, A., Ly, M. Delatour, B 2007) One-year longitudinal evaluation of sensori-motor functions in APP751SL transgenic mice. Genes Brain Behav 7 (Suppl. 1 67 75.
104. Lee, V.M., Goedert, M. Trojanowski, J.Q 2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24, 1121 1159.
105. Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M. Ashe, K.H 2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352 357.
106. van Leuven, F 2000) Single and multiple transgenic mice as models for Alzheimer's disease. Prog Neurobiol 61, 305 312.
107. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.E., Jondro, P.D., Schmidt, S.D. Wang, K 1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973 977.
108. Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Paul Murphy, M., Baker, M., Yu, X., Duff, K., Hardy, J., Corral, A., Lin, W.L., Yen, S.H., Dickson, D.W., Davies, P. Hutton, M 2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25, 402 405.
109. Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., Yen, S.H., Sahara, N., Skipper, L., Yager, D., Eckman, C., Hardy, J., Hutton, M. McGowan, E 2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487 1491.
110. Lim, L.P., Glasner, M.E., Yekta, S., Burge, C.B. Bartel, D.P 2003) Vertebrate microRNA genes. Science 299, 1540.
111. Lin, L., LeBlanc, C.J., Deacon, T.W. Isacson, O 1998) Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system. Neuroreport 9, 547 552.
112. Lipp, H.P. Wolfer, D.P 2003) Genetic background problems in the analysis of cognitive and neuronal changes in genetically modified mice. Clin Neurosci Res 3, 223 231.
113. Mailliot, C., Sergeant, N., Bussiere, T., Caillet-Boudin, M.L., Delacourte, A. Buee, L 1998) Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 433, 201 204.
114. Mandelkow, E.M. Mandelkow, E 1998) Tau in Alzheimer's disease. Trends Cell Biol 8, 425 427.
115. Mandelkow, E.M., Stamer, K., Vogel, R., Thies, E. Mandelkow, E 2003) Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 24, 1079 1085.
116. Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D. Games, D 1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci 16, 5795 5811.
117. Masliah, E., Sisk, A., Mallory, M. Games, D 2001) Neurofibrillary pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. J Neuropathol Exp Neurol 60, 357 368.
118. Mattson, M.P 2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631 639.
119. Mayford, M., Bach, M.E., Huang, Y.Y., Wang, L., Hawkins, R.D. Kandel, E.R 1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274, 1678 1683.
120. McGowan, E., Eriksen, J. Hutton, M 2006) A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet 22, 281 289.
121. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. Stadlan, E.M 1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939 944.
122. McKhann, G.M., Albert, M.S., Grossman, M., Miller, B., Dickson, D. Trojanowski, J.Q 2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58, 1803 1809.
123. Melrose, H.L., Lincoln, S.J., Tyndall, G.M. Farrer, M.J 2006) Parkinson's disease: a rethink of rodent models. Exp Brain Res 173, 196 204.
124. Mendez, M.F. McMurtray, A 2006) Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations. Am J Alzheimers Dis Other Demen 21, 281 286.
125. Mott, R.T., Dickson, D.W., Trojanowski, J.Q., Zhukareva, V., Lee, V.M., Forman, M., Van Deerlin, V., Ervin, J.F., Wang, D.S., Schmechel, D.E. Hulette, C.M 2005) Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. J Neuropathol Exp Neurol 64, 420 428.
126. Mucke, L., Masliah, E., Yu, G.Q., Mallory, M., Rockenstein, E.M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K. McConlogue, L 2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20, 4050 4058.
127. Muyllaert, D., Kremer, A., Jaworski, T., Borghgraef, P., Devijver, H., Croes, S., Dewachter, I. van Leuven, F 2007) GSK-3beta,α or the link between amyloid and tau pathology? Genes Brain Behav 7 (Suppl. 1 57 66.
128. Neumann, M., Schulz-Schaeffer, W., Crowther, R.A., Smith, M.J., Spillantini, M.G., Goedert, M. Kretzschmar, H.A 2001) Pick's disease associated with the novel Tau gene mutation K369I. Ann Neurol 50, 503 513.
129. Neve, R.L., Harris, P., Kosik, K.S., Kurnit, D.M. Donlon, T.A 1986) Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res 387, 271 280.
130. Nicholl, D.J., Greenstone, M.A., Clarke, C.E., Rizzu, P., Crooks, D., Crowe, A., Trojanowski, J.Q., Lee, V.M. Heutink, P 2003) An English kindred with a novel recessive tauopathy and respiratory failure. Ann Neurol 54, 682 686.
131. Nicoll, J.A.R., Wilkinson, D., Holmes, C., Steart, P., Markham, H. Weller, R.O 2003) Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat Med 9, 448 452.
132. Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., Berry, R. Vassar, R 2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26, 10129 10140.
133. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B.P. LaFerla, F.M 2003a) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063 1070.
134. Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., Metherate, R., Mattson, M.P., Akbari, Y. LaFerla, F.M 2003b) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409 421.
135. Oddo, S., Billings, L., Kesslak, J.P., Cribbs, D.H. LaFerla, F.M 2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321 332.
136. Ogilvie, J.M. Speck, J.D 2002) Dopamine has a critical role in photoreceptor degeneration in the rd mouse. Neurobiol Dis 10, 33 40.
137. Orgogozo, J.M., Gilman, S., Dartigues, J.F., Laurent, B., Puel, M., Kirby, L.C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., Michel, B.F., Boada, M., Frank, A. Hock, C 2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61, 46 54.
138. Owen, E.H., Logue, S.F., Rasmussen, D.L. Wehner, J.M 1997) Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience 80, 1087 1099.
139. Paulus, W. Selim, M 1990) Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol (Berl) 81, 89 94.
140. Polymeropoulos, M.H., Lavedan, C., Leroy, E. et al 1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045 2047.
141. Price, D.L. Sisodia, S.S 1998) Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21, 479 505.
142. Ramsden, M., Kotilinek, L., Forster, C., Paulson, J., McGowan, E., SantaCruz, K., Guimaraes, A., Yue, M., Lewis, J., Carlson, G., Hutton, M. Ashe, K.H 2005) Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 25, 10637 10647.
143. Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F., Cheng, I.H., Wu, T., Gerstein, H., Yu, G.Q. Mucke, L 2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750 754.
144. Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K. Tsuda, T 1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775 778.
145. Rosso, S.M., van Herpen, E., Pijnenburg, Y.A., Schoonenboom, N.S., Scheltens, P., Heutink, P. van Swieten, J.C 2003) Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations. Arch Neurol 60, 1209 1213.
146. Santa Cruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., Forster, C., Yue, M., Orne, J., Janus, C., Mariash, A., Kuskowski, M., Hyman, B., Hutton, M. Ashe, K.H 2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476 481.
147. Sassin, I., Schultz, C., Thal, D.R., Rub, U., Arai, K., Braak, E. Braak, H 2000) Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol (Berl) 100, 259 269.
148. Schalomon, P.M. Wahlsten, D 2002) Wheel running behavior is impaired by both surgical section and genetic absence of the mouse corpus callosum. Brain Res Bull 57, 27 33.
149. Schenk, D 2002) Opinion: amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning. Nat Rev Neurosci 3, 824 828.
150. Schenk, D., Barbour, R., Dunn, W. et al 1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173 177.
151. Schimanski, L.A., Wahlsten, D. Nguyen, P.V 2002) Selective modification of short-term hippocampal synaptic plasticity and impaired memory extinction in mice with a congenitally reduced hippocampal commissure. J Neurosci 22, 8277 8286.
152. Schindowski, K., Bretteville, A., Leroy, K., Begard, S., Brion, J.P., Hamdane, M. Buee, L 2006) Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 169, 599 616.
153. Schoenfeld, T.A. Obar, R.A 1994) Diverse distribution and function of fibrous microtubule-associated proteins in the nervous system. Int Rev Cytol 151, 67 137.
154. Seabrook, G.R. Rosahl, T.W 1999) Transgenic animals relevant to Alzheimer's disease. Neuropharmacology 38, 1 17.
155. Sergeant, N., David, J.P., Goedert, M., Jakes, R., Vermersch, P., Buee, L., Lefranc, D., Wattez, A. Delacourte, A 1997) Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications. J Neurochem 69, 834 844.
156. Sergeant, N., Delacourte, A. Buee, L 2005) Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 1739, 179 197.
157. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G. Holman, K 1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754 760.
158. Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine,
159. Sidman, R.L. Green, M.C 1965) Retinal degeneration in the mouse: location of the rd locus in linkage group XVII. J Hered 56, 23 29.
160. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. Goedert, M 1997) Alpha-synuclein in Lewy bodies. Nature 388, 839 840.
161. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A. Ghetti, B 1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 95, 7737 7741.
162. Spires, T.L. Hyman, B.T 2005) Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2, 423 437.
163. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. Mandelkow, E.M 2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156, 1051 1063.
164. Stelzmann, R.A., Schnitzlein, H.N. Murtagh, F.R 1995) An English translation of Alzheimer's 1907 paper, 'Uber eine eigenartige Erkankung der Hirnrinde'. Clin Anat 8, 429 431.
165. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P.A., Waridel, C., Calhoun, M.E., Jucker, M., Probst, A., Staufenbiel, M. Sommer, B 1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 94, 13287 13292.
166. Tanemura, K., Murayama, M., Akagi, T., Hashikawa, T., Tominaga, T., Ichikawa, M., Yamaguchi, H. Takashima, A 2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 22, 133 141.
167. Tanzi, R.E. Bertram, L 2001) New frontiers in Alzheimer's disease genetics. Neuron 32, 181 184.
168. Tickoo, S. Russell, S 2002) Drosophila melanogaster as a model system for drug discovery and pathway screening. Curr Opin Pharmacol 2, 555 560.
169. Tomlinson, B.E., Blessed, G. Roth, M 1968) Observations on the brains of non-demented old people. J Neurol Sci 7, 331 356.
170. Vanier, M.T., Neuville, P., Michalik, L. Launay, J.F 1998) Expression of specific tau exons in normal and tumoral pancreatic acinar cells. J Cell Sci 111, 1419 1432.
171. Victoroff, J., Zarow, C., Mack, W.J., Hsu, E. Chui, H.C 1996) Physical aggression is associated with preservation of substantia nigra pars compacta in Alzheimer disease. Arch Neurol 53, 428 434.
172. Wahlsten, D 1982) Deficiency of corpus callosum varies with strain and supplier of the mice. Brain Res 239, 329 347.
173. Wahlsten, D., Metten, P., Phillips, T.J. et al 2003) Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol 54, 283 311.
174. Wahlsten, D., Bachmanov, A., Finn, D.A. Crabbe, J.C 2006) Stability of inbred mouse strain differences in behavior and brain size between laboratories and across decades. Proc Natl Acad Sci U S A 103, 16364 16369.
175. Weingarten, M.D., Lockwood, A.H., Hwo, S.Y. Kirschner, M.W 1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72, 1858 1862.
176. Whishaw, I.Q 1985) Cholinergic receptor blockade in the rat impairs locale but not taxon strategies for place navigation in a swimming pool. Behav Neurosci 99, 979 1005.
177. Wirths, O., Weis, J., Kayed, R., Saido, T.C. Bayer, T.A 2006) Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol Aging 28, 1689 1699.
178. Wong, P.C., Cai, H., Borchelt, D.R. Price, D.L 2002) Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci 5, 633 639.
179. Yasuda, M., Takamatsu, J., D'Souza, I., Crowther, R.A., Kawamata, T., Hasegawa, M., Hasegawa, H., Spillantini, M.G., Tanimukai, S., Poorkaj, P., Varani, L., Varani, G., Iwatsubo, T., Goedert, M., Schellenberg, D.G. Tanaka, C 2000) A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto). Ann Neurol 47, 422 429.
180. Yasuda, M., Nakamura, Y., Kawamata, T., Kaneyuki, H., Maeda, K. Komure, O 2005) Phenotypic heterogeneity within a new family with the MAPT p301s mutation. Ann Neurol 58, 920 928.
181. Yen, S.H., Crowe, A. Dickson, D.W 1985) Monoclonal antibodies to Alzheimer neurofibrillary tangles. 1. Identification of polypeptides. Am J Pathol 120, 282 291.
182. Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.M., Iwata, N., Saido, T.C., Maeda, J., Suhara, T., Trojanowski, J.Q. Lee, V.M 2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337 351.
183. Zarranz, J.J., Ferrer, I., Lezcano, E., Forcadas, M.I., Eizaguirre, B., Atares, B., Puig, B., Gomez-Esteban, J.C., Fernandez-Maiztegui, C., Rouco, I., Perez-Concha, T., Fernandez, M., Rodriguez, O., Rodriguez-Martinez, A.B., de Pancorbo, M.M., Pastor, P. Perez-Tur, J 2005) A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64, 1578 1585.
184. Zehr, C., Lewis, J., McGowan, E., Crook, J., Lin, W.L., Godwin, K., Knight, J., Dickson, D.W. Hutton, M 2004) Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice. Neurobiol Dis 15, 553 562.